156 results on '"Ambrosino, Donna M."'
Search Results
2. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates
3. Therapy with a Severe Acute Respiratory Syndrome-Associated Coronavirus-Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters
4. Development and Characterization of a Severe Acute Respiratory Syndrome-Associated CoronavirusNeutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice [with Discussion]
5. Normal IgG and Impaired IgM Responses to Polysaccharide Vaccines in Asplenic Patients
6. Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein
7. Pneumococcal Conjugate Vaccine Primes for Antibody Responses to Polysaccharide Pneumococcal Vaccine after Treatment of Hodgkin's Disease
8. Treatment with monoclonal antibodies against clostridium difficile toxins
9. Evidence for antibody as a protective correlate for COVID-19 vaccines
10. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates
11. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
12. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
13. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
14. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
15. Effect of monophosphoryl lipid A (MPL ®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM 197 conjugate vaccine in healthy toddlers
16. Antibody Responses to Polysaccharide and Polysaccharide-Conjugate Vaccines after Treatment of Hodgkin Disease
17. Antibody Response of Infants to Haemophilus influenzae Type b Capsular Polysaccharide Combined with Bordetella pertussis
18. Passive Immunization against Disease Due to Haemophilus influenzae Type b: Concentrations of Antibody to Capsular Polysaccharide in High-Risk Children
19. Simultaneous Administration of Vaccines for Haemophilus influenzae Type b, Pneumococci, and Meningococci
20. κ and λ Light Chain Composition of Antibody to the Capsular Polysaccharide of Haemophilus influenzae Type b
21. History of passive antibody administration for prevention and treatment of infectious diseases
22. High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody
23. Prevention of Haemophilus influenzae type B infections in high-risk infants treated with bacterial polysaccharide immune globulin
24. An immunodeficiency characterized by impaired antibody responses to polysaccharides
25. Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1
26. Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
27. Blood-Group-A-Like Substance in a Preparation of Pneumococcal Vaccine
28. Treatment with Monoclonal Antibodies againstClostridium difficileToxins
29. Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
30. 751b Phase II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. difficile Recurrence
31. Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins
32. Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile -Induced Mortality in Hamsters
33. Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor
34. Effect of monophosphoryl lipid A (MPL®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM197 conjugate vaccine in healthy toddlers
35. Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions
36. RESPIRATORY SYNCYTIAL VIRUS VACCINES
37. Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Assessment of T Helper Cell Response in a Murine Model of Respiratory Syncytial Virus (RSV) Infection • 739
38. T Cells and Natural Killer Cells Regulate Human IgG Subclass Concentrations in SCID Mice
39. POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE MARROW TRANSPLANT PATIENTS1
40. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children
41. Critical Appraisal of Immunization Strategies for Prevention of Infection in the Compromised Host
42. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants
43. Response to Haemophilus influenzae type B conjugate vaccine in children undergoing splenectomy
44. Interpretation of IgG subclass values: A comparison of two assays
45. Haemophilus influenzae type b unsuspected bacteremia.
46. POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE MARROW TRANSPLANT PATIENTS1.
47. IgG1 IgG2 and IgM responses to two Haemophilus influenzaetype b conjugate vaccines in young infants
48. Recombinant Interleukin-2 Infusions and Decreased IgG2 Subclass Concentrations
49. Proliferation of resting B cells is modulated by CR2 and CR1
50. Recurrent Sinopulmonary Infection and Impaired Antibody Response to Bacterial Capsular Polysaccharide Antigen in Children with Selective IgG-Subclass Deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.